mohsin shah

Dr. mohsin shah

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Nanotechnology Reviews
Verified
Journal Article
Open access
PDF file
RYRehana Yasmin
Rehana Yasmin
MSmohsin shah
mohsin shah
SKSaeed Ahmad Khan
Saeed Ahmad Khan
RARoshan Ali
Roshan Ali
Gelatin is a protein obtained from the hydrolysis of collagen. Gelatin is an attractive biodegradable material for use in nano-biotechnology and nano-pharmaceutics. Gelatin nanoparticles (NPs) have been widely used as drug and gene carrier to targeted sick tissues including cancer, tuberculosis, HIV infection along with the treatment of vasospasm and restenosis, due to its biocompatibility and biodegradability. For instance, coating with gelatin lowers the cytotoxicity of quantum dots. Moreover, gelatin NPs have the ability to cross the blood-brain barrier, hence proven as a promising candidate to target brain disorders. Macrophage targeting with gelatin NPs for remedy of different diseases is repeatedly reported in previous years. In tissue engineering gelatin is actively utilized for construction of biological and life-long 3D scaffolds for bio-artificial tissues and organ production. Gelatins have a wide range of potential applications which needs to be unraveled in more detail. This review is mainly focused on the applications of gelatin NPs in biomedical sciences.

11 April 2018 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MYMuhammad I. Ul Akbar Yousufzai
Muhammad I. Ul Akbar Yousufzai
EHElia S. Harmatz
Elia S. Harmatz
MSmohsin shah
mohsin shah
MMMuhammad O. Malik
Muhammad O. Malik
KGKi A. Goosens
Ki A. Goosens
Prolonged stressor exposure in adolescence enhances the risk of developing stress-sensitive mental illnesses, including posttraumatic stress disorder (PTSD), for many years following exposure cessation, but the biological underpinnings of this long-term vulnerability are unknown. We show that severe stressor exposure increased circulating levels of the hormone acyl-ghrelin in adolescent rats for at least 130 days and in adolescent humans for at least 4.5 years. Using a rodent model of longitudinal PTSD vulnerability in which rodents with a history of stressor exposure during adolescence display enhanced fear in response to fear conditioning administered weeks after stressor exposure ends, we show that systemic delivery of a ghrelin receptor antagonist for 4 weeks surrounding stressor exposure (2 weeks during and 2 weeks following) prevented stress-enhanced fear memory. These data suggest that protracted exposure to elevated acyl-ghrelin levels mediates a persistent vulnerability to stress-enhanced fear after stressor exposure ends.

4 November 2019 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
DADurr-E-Shewar Ali
Durr-E-Shewar Ali
MSmohsin shah
mohsin shah
AAAsif Ali
Asif Ali
MMMuhammad Omar Malik
Muhammad Omar Malik
FRFarhat Rehman
Farhat Rehman
SVSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
Elevated serum levels of inflammatory mediators in conditions such as PCOS reflect a low-grade chronic inflammation and this has been attributed to be associated with insulin-resistance in PCOS. Therefore, insulin-sensitizing agents are suggested to improve both reproductive as well as metabolic aspects of PCOS. This study aimed to compare the effects of metformin taken alone with that of a combination of metformin and pioglitazone on menstrual cycle, hormonal parameters, insulin resistance, and inflammatory biomarkers in women with PCOS. One hundred and six women with PCOS participated in the study. All subjects were randomized into two-arm intervention groups (Arm 1 and 2). Participants in Arm-1 received metformin (500 mg BD) daily while those in Arm-2 a combination of metformin (500 mg BD) and pioglitazone (15 mg BD) for 12 wks. Serum levels of IL-6 and IL-8 were measured using ELISA whereas insulin resistance was assessed using HOMA-IR. At baseline women with PCOS had significantly elevated circulating concentrations of IL-6 and IL-8. Treatment decreased IL-6 in both the groups, however, only the combination group showed a significant decrease (p=0.005). Serum IL-8 level had a significant decrease after treatment in both groups (p <0.001). HOMA-IR and insulin levels also decreased in both the groups (both p <0.001). Testosterone, FSH, and prolactin significantly decreased in both groups. LH also decreased in both groups, however, the change was significant only in the combination group (p=0.013). Combination of metformin and pioglitazone therapy was more effective as compared to metformin alone in reducing the levels of IL-6 and IL-8 as well as insulin resistance in PCOS.

28 July 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Salvatore Giovanni VitaleSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
Anna Maria FulghesuAnna Maria Fulghesu
Anna Maria Fulghesu
MMMislav Mikuš
Mislav Mikuš
RWRafał Watrowski
Rafał Watrowski
Maurizio Nicola D'AlterioMaurizio Nicola D'Alterio
Maurizio Nicola D'Alterio
Stefano AngioniStefano Angioni
Stefano Angioni
MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of post-transcriptional gene expression during tissue development and differentiation. They are involved in the regulation of manifold metabolic and hormonal processes and, within the female reproductive tract, in oocyte maturation and folliculogenesis. Altered miRNA levels have been observed in oncological and inflammatory diseases, diabetes or polycystic ovary syndrome (PCOS). Therefore, miRNAs are proving to be promising potential biomarkers. In women with PCOS, circulating miRNAs can be obtained from whole blood, serum, plasma, urine, and follicular fluid. Our systematic review summarizes data from 2010–2021 on miRNA expression in granulosa and theca cells; the relationship between miRNAs, hormonal changes, glucose and lipid metabolism in women with PCOS; and the potential role of altered miRNAs in fertility (oocyte quality) in PCOS. Furthermore, we discuss miRNAs as a potential therapeutic target in PCOS and as a diagnostic marker for PCOS.

19 June 2018 in Advances in Therapy
Verified
Journal Article
Closed access
PDF file
HSHenna Salman
Henna Salman
MSmohsin shah
mohsin shah
AAAsif Ali
Asif Ali
AAAsma Aziz
Asma Aziz
Salvatore Giovanni VitaleSalvatore Giovanni Vitale
Salvatore Giovanni Vitale

28 September 2022 in Endocrine
Verified
Journal Article
Closed access
PDF file
SHSehresh Hassan
Sehresh Hassan
MSmohsin shah
mohsin shah
MMMuhammad Omar Malik
Muhammad Omar Malik
EEEhtesham Ehtesham
Ehtesham Ehtesham
SHSyed Hamid Habib
Syed Hamid Habib
BRBushra Rauf
Bushra Rauf